AMPEL BioSolutions ^Companies

AMPEL BioSolutions is a precision medicine company that focuses on commercializing gene expression tests for blood or tissue samples. Their tests provide decision support by determining disease status, identifying molecular pathways, and predicting drug options. Their first product, LuGENE, is a CLIA-certified blood test for lupus patients that assesses disease state/flares and best drug options. AMPEL's technology covers over 95% of all known genes and is disease agnostic, allowing for potential expansion into new disease indications without developing a new test. They also provide their genomic platform, bioinformatic tools, and ML/AI algorithms to Pharma/Biotech companies for clinical trial design, management, and patient stratification.